Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

Overview

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

In 1989, the Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Persons Infected with the Human Immunodeficiency Virus became the first HIV-related treatment guideline published by the U.S. government.[38] This guideline was published in the Morbidity and Mortality Weekly Report (MMWR), which was the most rapid mode of publication at the time. It was followed by a guideline on prevention of Mycobacterium avium complex disease in 1993.[39] In 1995, these guidelines were expanded to include the treatment of 18 HIV-related OIs. In 2004, information about the prevention of HIV-related OIs was incorporated into the guidelines. The NIH, the CDC, and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) now jointly co-sponsor these guidelines,[4,40-42] which have been published in peer-reviewed journals and/or the MMWR in 1997, 1999, and 2002.[41-53] Since 2009, the guidelines have been managed as a living document on the web with each chapter reviewed quarterly by the guidelines committee. Updates are published as often and as promptly as deemed appropriate by the guidelines committee. To view the latest update, please visit https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/whats-new-guidelines 

Recommendations

To view the full guideline, please visit AIDSinfo's website.